The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Among older adults and adults with low atherosclerotic cardiovascular disease risk, use of aspirin decreased after 2019.

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

A new study published in the Nature Scientific Reports highlighted the potential benefits of aspirin in reducing biochemical recurrence (BCR) rates following robot-assisted radical ...

Three-year results from the ALASCCA trial (NCT02647099), presented at the 2025 ASCO Gastrointestinal Cancer Symposium, showed ...

Suzetrigine (Journavx) is the first non-opioid pain medication to be approved in the US in 20 years. It could help over 80 million Americans living with severe acute pain, while reducing the effects ...

Acetaminophen, or Tylenol, changes our perception of pain. “It’s a very safe medication to take — you can even take it during pregnancy — but it’s not necessarily addressing the inflammation that ...

AGX101: A TM4SF1-directed tubulin inhibitor conjugate in ongoing first-in-human trial including GI cancers. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This ...

Aspirin as Effective as Blood Thinner Injections ... 24-fold increased risk of venous thromboembolism (VTE) compared with non-obese women not using the drugs, according to ...

Aspirin reduced disease recurrence in patients PI3K-mutated colorectal cancer, underscoring the value of early genomic ...

Giving blood is a great way to support your community while also taking care of your own health. You can find blood drives ...